flowerchefstocks
Posted - 1 week ago
@Mitchee01 Really good article think it might have helped people see the true potential of the science. Anyone see the market cap of $BIXT or $GLTO - Super cheap. Both under $10 million. Gotta listen to this video. I think these other galectin companies could represent big upside if $GALT readout is good and we all know its almost a given. https://www.youtube.com/watch?v=YGeoim7A_jM
History101
Posted - 1 week ago
$BIXT This is the kind of drug that Bobby Kennedy will love!!
flowerchefstocks
Posted - 1 week ago
$GALT Disrupting Merck - great article that speaks to the power of galectin blockers and how important it is for Keytruda to even work. See this article conclusively proves that Galectin-3 occupies the receptor binding location of PD-1 and thats bad for the PD-1 blockers. Great detail in this article. $BIXT $GLTO mentions https://www.insiderfinancial.com/post/galectin-therapeutics-nasdaq-galt-disrupting-mercks-cancer-dominance
flowerchefstocks
Posted - 2 weeks ago
@longterminvs you must be talking about $BIXT b/c $GALT never talks. I think close to 90 mil shares which isnt that much more than GALT. Yes hes got some energy - I guess you don't care for it but what I find interesting is that he appears to be a cheerleader for all Galectin science. Why would he talk about his competition so much if he had an inferior molecule. Their drugs were made much later in time so I think they might have more activity and the Oral Gal-3 drug had 100% efficacy - that is quite rare. https://www.youtube.com/watch?v=vIJwatXmZ6Y
flowerchefstocks
Posted - 10/31/24
$BIXT Going to listen to this in 30 min Looks like hes going to be talking about Galectins and cancer. Had me at Galectins https://x.com/MikeSheikh2/status/1851658320710664211 $GALT $GLTO $GLYC
flowerchefstocks
Posted - 10/30/24
$MRK This is BIG News - They found out why Keytruda doesn't work in 60% of the people they are treating. The good news they can make Keytruda 100% effective - the bad news its going to cost 60% of existing patients. Bigger news is that if the combine drug with a #galectin antagonist they get back the 60% they lost. https://www.linkedin.com/pulse/keytruda-neutralized-galectin-3-over-60-patients-michael-sheikh-mcowc/ $BIXT $GLTO $GALT
flowerchefstocks
Posted - 10/30/24
@Expharmaguy @smolcapcat Are you looking at any of the commentary on $BIXT because they have an oral Gal-3 inhibitor. if they get any money could be a threat. Did you see this video https://www.youtube.com/watch?v=YGeoim7A_jM They are clearly talking about GALT's readout. Actually you have to look at their youtube channel - lots of stuff about GALT on there.
flowerchefstocks
Posted - 10/30/24
@Steadynwise $MRK is the logical target but $GALT really isnt positioned in cancer like $GLTO or $BIXT for that matter. GALT cant expect someone else to run their cancer trials like they have done in the past.
Selett
Posted - 10/29/24
$BIXT anyone know share count / cash on hand currently? Q burn rate?
flowerchefstocks
Posted - 10/28/24
@smolcapcat $BIXT $GLTO are the ones that have the oral formulation of #GAL3 but I think BIXT is the only one that completed P2 but don't really have a clue on the bioavailability. All we know is 100% responders rate so that's a good clue that it's bioavailable but dont know any more than that.
pepper100
Posted - 10/24/24
$BIXT Volume today?
RetireRich44
Posted - 10/22/24
$BIXT Any informed guesses on what this stock price will be in five years? Is GALT any competition?
robsap
Posted - 10/22/24
$BIXT Let's get to 52 high first.
pepper100
Posted - 1 month ago
$BIXT Bullish!!!
History101
Posted - 1 month ago
$BIXT 195 watching 10/3/2024
javanz
Posted - 09/28/24
$BIXT So why make the presentation so comical and boring why not do like in those commercials where the guy is pointing out things on a Black Board and she just shuts him down with an easier way
richapd
Posted - 09/28/24
$BIXT The directors and CEO purchased considerable shares early January '24 and the company made a statement 6 week later regarding the progress of the PH2 dose finding trial for Covid. They again purchased considerable shares around August 25 so perhaps we shall hear in October the results from that trial. With the low volume/low MC that would send the SP to the stratosphere.
History101
Posted - 09/26/24
$BIXT up 17% so far today, lovin my 9.2 cent cost basis!!
BlazingStocks
Posted - 09/25/24
$BIXT - 75th Emerging Growth Conference on September 26, 2024...
11:25 - 11:55
Bioxytran, Inc. (OTCQB: BIXT)
Keynote speakers: Mike Sheikh, Executive Vice President Business Development
https://finance.yahoo.com/news/presenting-emerging-growth-conference-75-110000580.html
BlazingStocks
Posted - 09/25/24
$BIXT News September 26, 2024
Presenting on the Emerging Growth Conference 75 Day 2 on September 26
https://finance.yahoo.com/news/presenting-emerging-growth-conference-75-110000580.html
BlazingStocks
Posted - 09/25/24
$BIXT - Bioxytran CCO Mike Sheikh will take on cancer metastasis in his interview at the Emerging Growth Conference on Thursday, Sept. 26, 2025 from 11:25 AM to 11:55 AM Eastern. Please click the registration link: tinyurl.com/3hpkm9j8
https://x.com/BioxytranInc/status/1838959542802985152?t=zMuO-lyU1yRTJ4qLyUjb6A&s=19
javanz
Posted - 2 months ago
$BIXT If they’re shorting your blessings eating them up wouldn’t be a bad thing: they either want out or want down for whatever reason imo
javanz
Posted - 2 months ago
$BIXT If the company truly has such a Glorious claim to their name you know that every Major is going after them so I would snatch any free shares down here
History101
Posted - 2 months ago
$BIXT 187 watching 9/19/2024
javanz
Posted - 2 months ago
$BIXT Seems like about the right time to make that move these babies boom with the right slapping
richapd
Posted - 2 months ago
@Kilarck I was referring to $bixt ceo and directors buying
